---
title: "Channel Therapeutics (CHRO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CHRO.US/norm.md"
symbol: "CHRO.US"
name: "Channel Therapeutics"
parent: "https://longbridge.com/en/quote/CHRO.US.md"
datetime: "2026-03-15T11:31:00.060Z"
locales:
  - [en](https://longbridge.com/en/quote/CHRO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CHRO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CHRO.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CHRO.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CHRO.US/norm.md)


# Channel Therapeutics (CHRO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -3.21 | -3.19 | -2.93 | -3.07 | -5.46 |
| ROE | 227.80% | 372.18% | 842.06% | -1495.67% | 385.71% |
| Revenue | - | - | - | - | - |
| Net income | -1.97M | -1.93M | -1.69M | -1.77M | -2.56M |

## Balance Sheet (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 911179.00 | 1.37M | 2.14M | 2.60M | 4.03M |
| Leverage | -0.2172 | -0.5045 | -1.50 | -14.26 | 3.57 |
| BVPS | -6.79 | -4.45 | -2.45 | -0.3134 | 1.96 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -632126.00 | -670264.00 | -177911.00 | -2.95M | -1.99M |
| Investing CF | - | - | - | - | - |
| Financing CF | 250000.00 | -71196.00 | -972284.00 | 1.59M | 5.67M |
| Free CF | 40001.00 | 36384.00 | -1.45M | -2.38M | -3.55M |